ClinicalTrials.Veeva

Menu

EVALUATION OF RESPIRATORY MECHANICS AND FUNCTIONALITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

U

Universidade Federal de Pernambuco

Status

Completed

Conditions

Pulmonary Disease, Chronic Obstructive

Study type

Observational

Funder types

Other

Identifiers

NCT03086590
UFPE-M1

Details and patient eligibility

About

To associate a lean mass, peripheral muscle strength, kinematic thoracic-abdominal, respiratory metabolic response, mobility and diaphragmatic thickness, verifying its relation with the obstruction level of COPD

Full description

Individuals with COPD present restriction in their daily lives due to changes and bodily disorders promoted by the disease, such as changes in types of muscle fibers and chronic inflammatory process, causing a low level of physical activity and quality of life, besides being closely Related to the need for hospitalizations and increased mortality. A cross-sectional study with a convenience sample was performed at the Laboratory of Cardiopulmonary Physiotherapy of the Federal University of Pernambuco during the period from December 2016 to February 2018. As measurements of body composition were performed with a bio-balance scale, Evaluation of the peripheral muscle strength will be used the dynamometer, a load cell and electromyography, a kinematic thoracic-abdominal will be measured by optoelectronic plethysmography, a respiratory metabolic response will be verified during the 6-minute walk test using the gas analyzer, and for evaluation of mobility and diaphragmatic thickness are used on ultrasound associated with pneumotachograph.

Enrollment

20 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Young adults, adults and elderly subjects

Exclusion criteria

  • Others respiratory diseases;
  • Heart diseases;
  • Those who are in some previous training program or rehabilitation;

Trial design

20 participants in 4 patient groups

Group 1
Description:
COPD mild. The individuals allocated to this group have FEV1 ≥ 80% predicted.
Group 2
Description:
COPD Moderate. The individuals allocated to this group have 50% ≤ FEV1 \< 80% predicted.
Group 3
Description:
COPD Severe. The individuals allocated to this group have 30% ≤ FEV1 \< 50% predicted.
Group 4
Description:
COPD Very severe. The individuals allocated to this group have FEV1 \< 30% predicted.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems